| Literature DB >> 10029323 |
M Gut1, C M Leutenegger, J B Huder, N C Pedersen, H Lutz.
Abstract
A one-tube reverse transcription-polymerase chain reaction (RT-PCR) for absolute feline coronavirus (FCoV) quantitation was developed. The assay is based on the 5' nuclease activity of the Thermus flavus (Tfl) polymerase and a fluorogenic probe which generates fluorescence when it is cleaved. The fluorogenic probe, also called TaqMan(TM) probe (Perkin Elmer, Foster City, USA), is an oligonucleotide designed to bind between the two PCR primers to the target cDNA and is labeled with a reporter and a quencher dye. In the intact probe, the quencher dye suppresses the fluorescence of the reporter dye by Forster-type energy transfer. During the polymerase extension steps the Tfl exonuclease activity cleaves the hybridised probe resulting in the generation of fluorescent emission of the reporter dye. The threshold cycle (C(T) value) indicates the increase of reporter fluorescence and is directly related to the initial amount of target cDNA or RNA, respectively. Fluorescence is monitored in real time after each cycle by a Perkin-Elmer ABI Prism 7700 Sequence Detector. After completion of amplification, the C(T) values of the samples are calculated back to a standard curve, generated by amplification of diluted standard molecules. The one-tube RT-PCR described below allows precise quantitation, is highly sensitive, rapid (no separate reverse transcription step and no post-amplification steps), easy to handle, allows for a high sample throughput, shows a very good reproducibility, and can be executed with a low risk of contamination. The design of the primers probe combination enables the detection of all known FCoV strains and is also useful for the detection of canine coronavirus, transmissible gastroenteritis virus and porcine respiratory coronavirus.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10029323 PMCID: PMC7185542 DOI: 10.1016/s0166-0934(98)00129-3
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014
Fig. 1Principles of the 5′ nuclease fluorogenic assay for feline coronavirus.
(a) Feline coronavirus (FCoV) primers and probe for the FCoV fluorogenic assay; (b) position of primers and probe in the sequence of the FCoV 7b gene
| Primer or probe | Sequence (5′→3′) | Length of fragment (bp) | |||
| (a) | |||||
| Forward primer FcoV1128f | GAT TTG ATT TGG CAA TGC TAG ATT T | ||||
| Reverse primer FcoV1229r | AAC AAT CAC TAG ATC CAG ACG TTA GCT | 102 | |||
| Probe FCoV1200p | |||||
| (b) | |||||
| 1001 | GGCAACCCGA | TGTCTAAAAC | TGGTCTTTCC | GAGGAATTAC | GGGTCATCGC |
| 1051 | GCTGCCTACT | CTTGTACAGA | ATGGTAAGCA | CGTGTAATAG | GAGGTACAAG |
| FCoV1128→ | |||||
| 1101 | CAACCCTATT | GCATATTAGG | AAGTTTAGAT | TTGATTTGGC | AATGCTAGAT |
| ←FCoV1200p | |||||
| 1151 | TTAGTAATTT | AGAGAAGTTT | AAAGATCCGC | TATGACGAGC | CAACAATGGA |
| ←FCoV1229r | |||||
| 1201 | AGAGCTAACG | TCTGGATCTA | GTGATTGTTT | AAAATGTAAA ATTGTTTGAA | |
| 1251 | AATTTTCCTT | TTGATAGTGA | TG | ||
Reporter dye (FAM) labeled nucleotide.
Quencher dye (TAMRA) labeled nucleotide.
Conformity of the feline coronavirus (FCoV) fluorogenic assay sequence with the sequence of canine coronavirus (CCV), transmissible gastroenteritis virus (TGEV), porcine respiratory coronavirus (PRCV), and human coronavirus 229E (HCV); the nonconformity between TaqMan™ and HCV sequence decreases the risk of contamination due to shedded human coronaviruses
| FCoV | GATTTGATTT | GGCAATGCTA | GATTTAGTAA | TTTAGAGAAG | T..TTAAAGATC | |
| CCV | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – .. – – – – – – – – – | |
| TGEV | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – .. – – – – – – – – – | |
| PRCV | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – .. – – – – – – – – – | |
| HCV | T–GG– – –ACG | CTAGTATAAC | TCA– – –CA– – | –G–GCT–G– – | –AA–C– – – – – –. | |
| FCoV | CGCTATGACG | AGCCAACAAT | GGAAGAGCTA | ACGTCTGGAT | CTAGTGATTG | TT |
| CCV | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – |
| TGEV | – – – – –C– – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – |
| PRCV | – – – – –C– – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – – – – – – – – – | – – |
| HCV | – – –AT– – – – – | – – – – – – – – – – | – – – – – – – –C– | GTCAT–T–TC | T–GAGACC–A | –C |
Cross-reactivity of the feline coronavirus (FCoV) fluorogenic assay with several FCoV strains and coronaviruses from other species
| Isolate | Kind of sample | Result |
| FIPV 204859 | Cell culture supernatant | Detectable |
| FIPV UCD 1 VP II | Cell culture supernatant | Detectable |
| UCD 5 | Cell culture supernatant | Detectable |
| FIPV UCD 8 | Ascites fluid | Detectable |
| FeCV UCD 1 | Faeces suspension | Detectable |
| FeCV RM | Faeces suspension | Detectable |
| Cell culture supernatant | Detectable | |
| Cell culture supernatant | Detectable | |
| Cell culture supernatant | Detectable | |
| Isolate 1 | Cell culture supernatant | Not detectable |
| Isolate 2 | Cell culture supernatant | Not detectable |
| Isolate 3 | Cell culture supernatant | Not detectable |
| Isolate 1 | Cell culture supernatant | Not detectable |
| Isolate 2 | Cell culture supernatant | Not detectable |
Sensitivity of feline coronavirus (FCoV) fluorogenic assay and nested FCoV reaction transcription-polymerase chain reaction (RT-PCR)
| Dilution | Fluorogenic assay | Nested RT-PCR | ||||
| 1/104 | + | + | + | + | + | + |
| 1/105 | + | + | + | + | + | + |
| 1/106 | + | + | + | + | + | + |
| 1/107 | + | + | + | + | + | − |
| 1/108 | − | + | + | − | − | − |
| 1/109 | + | − | − | − | − | − |
| 1/1010 | − | − | − | − | − | − |
| 1/1011 | − | − | − | − | − | − |
Coefficient of variation (in %) of precision within-run and precision from run-to-run
| Standard RNA (copies) | Complete virus (dilution) | |||||
| 50 | 500 | 5000 | 1:106 | 1:105 | 1:104 | |
| CV within-run | 1.50 | 0.88 | 0.69 | 0.57 | 0.91 | 0.59 |
| CV from run-to-run | 3.42 | 2.10 | 1.70 | 2.82 | 2.09 | 1.16 |
Fig. 2Amplification efficiencies of standard RNA and complete virus.